Get the Stockscreener App
2.20
1.85%
+0.04
After Hours:
2.05
-0.15
-6.82%
eFFECTOR Therapeutics Inc Stock (EFTR) Forecast
The eFFECTOR Therapeutics Inc (EFTR) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.7585, representing a +70.84% increase from the current price of $2.20. The highest analyst price target is $3.142, and the lowest is $4.375.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month EFTR Price Target
Average 7.0793
(+221.79% Upside)
Is eFFECTOR Therapeutics Inc (EFTR) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 32.10 | Neutral |
| STOCH(9,6) | 80.48 | Sell |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -1.7396 | Buy |
| ADX(14) | 37.73 | Sell |
| William %R | -18.92 | Sell |
| CCI(14) | 110.04 | Buy |
Buy: 2
Sell: 4
Neutral: 1
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.015
Buy
|
2.2283
Sell
|
| MA20 |
2.0287
Buy
|
3.3343
Sell
|
| MA50 |
8.4578
Sell
|
6.012
Sell
|
| MA100 |
7.3591
Sell
|
6.2951
Sell
|
| MA200 |
3.9895
Sell
|
4.919
Sell
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, EFTR could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 12 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on EFTR, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 32.1 indicates that EFTR is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 80.48 indicates that EFTR is oversold. This means that EFTR price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that EFTR is oversold. This suggests that EFTR price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 37.73 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 110.04 indicates that EFTR is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term EFTR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about eFFECTOR Therapeutics Inc financial reports and earnings history, eFFECTOR Therapeutics Inc (EFTR) stock could reach $5.3782 by 2030, $69.55 by 2040 and $71.86 by 2050. See the projected annual prices until 2050 of the eFFECTOR Therapeutics Inc stock below:
- eFFECTOR Therapeutics Inc (EFTR) is expected to reach an average price of $29.88 in 2035, with a high prediction of $31.04 and a low estimate of $29.89. This indicates an $1,258% rise from the last recorded price of $2.20.
- eFFECTOR Therapeutics Inc (EFTR) stock is projected to chart a bullish course in 2040, with an average price target of $68.95, representing an $3,034% surge from its current level. The forecast ranges from a conservative $69.01 to a sky-high $69.55.
- Our analysts predict eFFECTOR Therapeutics Inc (EFTR) to jump 506.07% by 2045, soaring from $14.37 to an average price of $13.33, potentially reaching $25.08. While $14.37 is the low estimate, the potential upside is significant.
- eFFECTOR Therapeutics Inc (EFTR) stock is expected to climb by 2050, reaching an average of $69.80, a $3,073% jump from its current level. However, a wide range of estimates exists, with high and low targets of $71.86 and $69.84, respectively, highlighting the market's uncertainty.
eFFECTOR Therapeutics Inc Stock (EFTR) Year by Year Forecast
eFFECTOR Therapeutics Inc Stock (EFTR) Price Forecast for 2024
Our forecast for EFTR stock price in 2024 now indicates an average price target of $9.0632 with a high forecast of $17.75 and a low forecast of $0.3764. The average prediction reflects an increase of +311.96% from the last recorded price of $2.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $3.8989 | $4.375 | $3.142 | +77.22% |
| July, 2024 | $8.2439 | $4.3809 | $7.1239 | +274.72% |
| August, 2024 | $5.3419 | $6.0369 | $6.2979 | +142.81% |
| September, 2024 | $7.6698 | $6.6889 | $6.9098 | +248.63% |
| October, 2024 | $7.9248 | $7.7568 | $7.4879 | +260.22% |
| November, 2024 | $7.4628 | $8.1618 | $8.1258 | +239.22% |
| December, 2024 | $8.3707 | $8.3598 | $8.2007 | +280.49% |
eFFECTOR Therapeutics Inc Stock (EFTR) Price Forecast for 2025
eFFECTOR Therapeutics Inc Stock (EFTR) is expected to reach an average price of $8.5643 in 2025, with a high prediction of $9.7836 and a low estimate of $7.345. This indicates an +289.29% rise from the last recorded price of $2.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $9.9957 | $8.6776 | $8.7657 | +354.35% |
| February, 2025 | $9.6737 | $9.5967 | $9.7427 | +339.71% |
| March, 2025 | $9.7116 | $9.8316 | $9.6277 | +341.44% |
| April, 2025 | $9.9068 | $9.7056 | $9.7611 | +350.31% |
| May, 2025 | $9.7585 | $9.7946 | $9.7836 | +343.57% |
| June, 2025 | $9.4428 | $9.4993 | $9.6116 | +329.22% |
| July, 2025 | $9.0474 | $9.0699 | $9.3375 | +311.25% |
| August, 2025 | $8.7654 | $8.8442 | $8.9345 | +298.43% |
| September, 2025 | $8.5353 | $8.5534 | $8.6325 | +287.97% |
| October, 2025 | $8.0584 | $8.1584 | $8.441 | +266.29% |
| November, 2025 | $7.7133 | $7.7764 | $7.9854 | +250.60% |
| December, 2025 | $7.3131 | $7.345 | $7.4634 | +232.42% |
eFFECTOR Therapeutics Inc Stock (EFTR) Price Forecast for 2026
The predicted value for eFFECTOR Therapeutics Inc (EFTR) in 2026 is set at an average of $5.8233. Estimates vary from a peak of $8.4451 to a trough of $3.2015, indicating an +164.70% surge from the present price of $2.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $7.1253 | $7.1293 | $7.1683 | +223.88% |
| February, 2026 | $6.7423 | $6.7816 | $7.0187 | +206.47% |
| March, 2026 | $6.0836 | $6.2102 | $6.5743 | +176.53% |
| April, 2026 | $5.473 | $5.4832 | $5.9422 | +148.77% |
| May, 2026 | $5.3002 | $5.3172 | $5.4172 | +140.92% |
| June, 2026 | $4.986 | $5.0191 | $5.1608 | +126.64% |
| July, 2026 | $4.5868 | $4.6012 | $4.9031 | +108.49% |
| August, 2026 | $4.3892 | $4.5061 | $4.4891 | +99.51% |
| September, 2026 | $4.034 | $4.064 | $4.2961 | +83.37% |
| October, 2026 | $3.552 | $3.662 | $3.902 | +61.45% |
| November, 2026 | $3.5342 | $3.4804 | $3.4881 | +60.64% |
| December, 2026 | $7.1251 | $3.2015 | $8.4451 | +223.87% |
eFFECTOR Therapeutics Inc Stock (EFTR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for eFFECTOR Therapeutics Inc (EFTR) is $10.58, with a high forecast of $21.08 and a low forecast of $0.0742. This indicates an +380.73% increase from the last price of $2.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $7.5371 | $5.4881 | $8.671 | +242.60% |
| February, 2027 | $13.37 | $7.3201 | $13.84 | +507.69% |
| March, 2027 | $0.0942 | $0.0742 | $15.00 | -95.72% |
| April, 2027 | $0.1662 | $0.1637 | $0.1862 | -92.45% |
| May, 2027 | $16.42 | $0.1683 | $15.26 | +646.27% |
| June, 2027 | $18.27 | $18.54 | $17.59 | +730.36% |
| July, 2027 | $21.49 | $18.67 | $20.96 | +876.99% |
| August, 2027 | $18.03 | $20.25 | $21.08 | +719.53% |
| September, 2027 | $20.96 | $19.66 | $20.20 | +852.71% |
| October, 2027 | $20.72 | $20.96 | $20.53 | +841.62% |
| November, 2027 | $21.25 | $20.95 | $20.75 | +865.98% |
| December, 2027 | $20.58 | $20.78 | $20.41 | +835.52% |
eFFECTOR Therapeutics Inc Stock (EFTR) Price Forecast for 2028
In 2028, eFFECTOR Therapeutics Inc (EFTR) is projected to reach an average price of $18.42, with a high projection of $21.46 and a low estimate of $15.38. This indicates an +737.27% rise from the last price of $2.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $21.06 | $20.81 | $20.46 | +857.39% |
| February, 2028 | $20.93 | $21.14 | $21.46 | +851.52% |
| March, 2028 | $20.84 | $20.96 | $20.97 | +847.42% |
| April, 2028 | $20.72 | $20.67 | $20.73 | +841.78% |
| May, 2028 | $20.14 | $20.18 | $20.48 | +815.59% |
| June, 2028 | $19.50 | $19.55 | $19.91 | +786.15% |
| July, 2028 | $18.86 | $18.89 | $19.31 | +757.05% |
| August, 2028 | $18.07 | $18.15 | $18.64 | +721.40% |
| September, 2028 | $17.51 | $17.53 | $17.85 | +695.85% |
| October, 2028 | $16.86 | $16.92 | $17.33 | +666.15% |
| November, 2028 | $15.94 | $16.00 | $16.46 | +624.53% |
| December, 2028 | $15.31 | $15.38 | $15.61 | +595.72% |
eFFECTOR Therapeutics Inc Stock (EFTR) Price Forecast for 2029
The 2029 price forecast for eFFECTOR Therapeutics Inc Stock (EFTR) is $10.95 on average, with a high prediction of $15.12 and a low estimate of $6.7795. This represents an +397.63% increase from the previous price of $2.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $14.60 | $14.61 | $15.12 | +563.85% |
| February, 2029 | $13.89 | $13.93 | $14.41 | +531.34% |
| March, 2029 | $12.90 | $13.03 | $13.64 | +486.31% |
| April, 2029 | $11.59 | $11.97 | $12.67 | +426.66% |
| May, 2029 | $11.37 | $11.39 | $11.73 | +416.74% |
| June, 2029 | $10.72 | $10.80 | $11.15 | +387.37% |
| July, 2029 | $10.08 | $10.16 | $10.56 | +358.19% |
| August, 2029 | $9.3782 | $9.4951 | $9.9022 | +326.28% |
| September, 2029 | $8.7845 | $8.8041 | $9.2021 | +299.29% |
| October, 2029 | $7.794 | $7.904 | $8.5981 | +254.27% |
| November, 2029 | $7.4441 | $7.4637 | $7.619 | +238.37% |
| December, 2029 | $3.5341 | $6.7795 | $7.2041 | +60.64% |
eFFECTOR Therapeutics Inc Stock (EFTR) Price Forecast for 2030
eFFECTOR Therapeutics Inc Stock (EFTR) is expected to reach an average price of $18.43 in 2030, with a high forecast of $35.03 and a low forecast of $1.8325. This signifies an +737.82% surge from the last price of $2.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.3742 | $2.0762 | $5.3782 | +98.83% |
| February, 2030 | $10.54 | $4.2402 | $11.01 | +379.01% |
| March, 2030 | $9.3923 | $5.1703 | $12.25 | +326.92% |
| April, 2030 | $2.4436 | $2.3417 | $12.05 | +11.07% |
| May, 2030 | $31.20 | $1.8325 | $30.04 | +1,318% |
| June, 2030 | $33.48 | $33.24 | $32.05 | +1,422% |
| July, 2030 | $35.53 | $32.95 | $35.00 | +1,515% |
| August, 2030 | $31.73 | $33.95 | $35.03 | +1,342% |
| September, 2030 | $33.70 | $33.28 | $32.67 | +1,432% |
| October, 2030 | $33.67 | $34.17 | $33.73 | +1,431% |
| November, 2030 | $33.88 | $33.75 | $33.49 | +1,440% |
| December, 2030 | $33.06 | $33.07 | $32.73 | +1,403% |
1.62%
0.15%
Cap:
|
Volume (24h):